Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v5-FR
Language French French
Date Updated 2023-04-06 2023-01-27
Drug Identification Number 00787019 00787019
Brand name MICRO ZN MICRO ZN
Common or Proper name MICRO ZN MICRO ZN
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients ZINC ZINC
Strength(s) 1MG 1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 10ML 10ML
ATC code B05XA B05XA
ATC description
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-01-30 2023-01-30
Estimated end date 2023-03-31 2023-04-14
Actual end date 2023-04-03
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Baxter item: 9400 Product is available on allocation based on 90% of historical volumes Baxter item: 9110 Product is available on allocation based on 90% of historical volumes
Health Canada comments